Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer

Journal of Digestive Diseases

Volumn 13, Issue 1, 2012, Pages 24-32

  Li, Jing Nan ^a   Zhao, Li ^a   Wu, Jun ^a   Wu, Bin ^a   Yang, Hong ^a   Zhang, Heng Hui ^b   Qian, Jia Ming ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Colon cancer; Gene profile; Rectal cancer; Signal pathway

Indexed keywords

ALPHA ACTININ 1; OLIGONUCLEOTIDE; PROTEIN P53;

ACAT1 GENE; AGED; ARTICLE; BIOINFORMATICS; CAMK2G GENE; CANCER TISSUE; CARCINOGENESIS; CELL CYCLE; CLINICAL ARTICLE; CLINICAL FEATURE; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INTERACTION; HUMAN; HUMAN TISSUE; MALE; METABOLISM; MICROARRAY ANALYSIS; MUTATION; PRIMARY TUMOR; PRIORITY JOURNAL; RECTUM CANCER; S100P GENE; SIGNAL TRANSDUCTION; TUMOR GENE;

ACETYL-COA C-ACETYLTRANSFERASE; ACTININ; AGED; CALCIUM-BINDING PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RECTAL NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84155174835     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2011.00551.x     Document Type: Article

References (38)

1. Ju JH, Chang SC, Wang HS etal. Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5, 474 cases in 20 years. Int J Colorectal Dis 2007; 22: 855-62.
2. Li M, Gu J. [Changing patterns of colorectal cancer over the recent two decades in China.] Zhonghua Wei Chang Wai Ke Za Zhi 2004; 7: 214-7 (in Chinese).
3. Li JN, Zhao L, Zheng WY, Miao Z, Tang XY, Qian JM. [The trends in clinical characteristics of colon cancer in last two decades.] Zhonghua Nei Ke Za Zhi 2010; 49: 226-9 (in Chinese).
4. Cheng L, Eng C, Nieman LZ, Kapadia AS, Du XL. Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol 2011; 34: 573-80.
5. Green J, Watson J, Roche M, Beral V, Patnick J. Stage, grade and morphology of tumors of the colon and rectum recorded in the Oxford Cancer Registry, 1995-2003. Br J Cancer 2007; 96: 140-2.
6. Vogelstein B, Fearon ER, Hamilton SR etal. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-32.
7. Frattini M, Balestra D, Suardi S etal. Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res 2004; 10: 4015-21.
8. Birkenkamp-Demtroder K, Olesen SH, Sørensen FB etal. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 2005; 54: 374-84.
9. Lindblom A. Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol 2001; 13: 63-9.
10. He QJ, Zeng WF, Sham JS etal. Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients. Cancer Genet Cytogenet 2003; 144: 112-8.
11. Cardoso J, Boer J, Morreau H, Fodde R. Expression and genomic profiling of colorectal cancer. Biochim Biophys Acta 2007; 1775: 103-37.
12. Wright GW, Simon RM. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003; 19: 2448-55.
13. Clarke R, Ressom HW, Wang A etal. The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat Rev Cancer 2008; 8: 37-49.
14. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004; 32: D277-80.
15. Yi M, Horton JD, Cohen JC, Hobbs HH, Stephens RM. WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinformatics 2006; 7: 30.
16. Draghici S, Khatri P, Tarca AL etal. A systems biology approach for pathway level analysis. Genome Res 2007; 17: 1537-45.
17. Li C, Li H. Network-constrained regularization and variable selection for analysis of genomic data. Bioinformatics 2008; 24: 1175-82.
18. Zhang JD, Wiemann S. KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor. Bioinformatics 2009; 25: 1470-1.
19. Wu X, Chen VW, Martin J etal. Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999. Cancer Epidemiol Biomarkers Prev 2004; 13: 1215-22.
20. Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL. Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database. Cancer 2010; 116: 4354-9.
21. Gervaz P, Bouzourene H, Cerottini JP etal. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Dis Colon Rectum 2001; 44: 364-72. Discussion 372-3.
22. Minoo P, Zlobec I, Peterson M, Terracciano L, Lugli A. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int J Oncol 2010; 37: 707-18.
23. Slattery ML, Curtin K, Wolff RK etal. A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum 2009; 52: 1304-11.
24. Hurst JH, Mendpara N, Hooks SB. Regulator of G-protein signally expression and function in ovarian cancer cell lines. Cell Mol Biol Lett 2009; 14: 153-74.
25. Xie Y, Wolff DW, Wei T etal. Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4. Cancer Res 2009; 69: 5743-51.
26. Uezu A, Horiuchi A, Kanda K etal. SGIP1alpha is an endocytic protein that directly interacts with phospholipids and Eps15. J Biol Chem 2007; 282: 26481-9.
27. Arumugam T, Logsdon CD. S100P: a novel therapeutic target for cancer. Amino Acids 2011; 41: 893-9.
28. Jiang L, Lai YK, Zhang J etal. Targeting S100P inhibits colon cancer growth and metastasis by Lentivirus-mediated RNA interference and proteomic analysis. Mol Med 2011; 17: 709-16.
29. Fuentes MK, Nigavekar SS, Arumugam T etal. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum 2007; 50: 1230-40.
30. Astrosini C, Roeefzaad C, Dai YY, Dieckgraefe BK, Jöns T, Kemmner W. REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis. Int J Cancer 2008; 123: 409-13.
31. Craig DH, Haimovich B, Basson MD. Alpha-actinin-1 phosphorylation modulates pressure-induced colon cancer cell adhesion through regulation of focal adhesion kinase-Src interaction. Am J Physiol Cell Physiol 2007; 293: C1862-74.
32. de Medina P, Genovese S, Paillasse MR etal. Auraptene is an inhibitor of cholesterol esterification and a modulator of estrogen receptors. Mol Pharmacol 2010; 78: 827-36.
33. Aamodt R, Jonsdottir K, Andersen SN, Bondi J, Bukholm G, Bukholm IR. Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas. Gastroenterol Res Pract 2009; 2009: 285830.
34. Bi X, Lin Q, Foo TW etal. Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis. Mol Cell Proteomics 2006; 5: 1119-30.
35. Hirayama A, Kami K, Sugimoto M etal. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 2009; 69: 4918-25.
36. Slattery ML, Herrick JS, Lundgreen A, Fitzpatrick FA, Curtin K, Wolff RK. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Carcinogenesis 2010; 31: 1604-11.
37. Curtin K, Samowitz WS, Wolff RK, Herrick J, Caan BJ, Slattery ML. Somatic alterations, metabolizing genes and smoking in rectal cancer. Int J Cancer 2009; 125: 158-64.
38. Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, N G. etal. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 2005; 23: 7518-28.